Radium-223 dichloride (xofigo)
Ended Awarded Last action
- Contract number
- 36C25024N0075
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$105,550 | |
| Funding Only Action | -$117,583 | |
| Original award | $223,133 |
About this award
This federal contract award is for the supply of RADIUM-223 DICHLORIDE (XOFIGO), a pharmaceutical product for the treatment of prostate cancer, to the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA). The prime contractor is Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The contract has a ceiling value of $105,550.00 and is a Blanket Purchase Agreement (BPA) call under Bayer's $840 million Federal Supply Schedule (FSS-61-IB) contract with the VA for pharmaceuticals and drugs. The contract is not set aside and was awarded on October 1, 2023, with a completion date of September 30, 2024. This award supports the VA's efforts to provide specialized cancer treatments and other essential medications to veterans through its integrated healthcare network.
Quick answers
Who was awarded contract 36C25024N0075?
36C25024N0075 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C25024N0075 worth?
The government has obligated $0 on 36C25024N0075.
Is contract 36C25024N0075 an order under another contract?
Yes. 36C25024N0075 is a BPA call under V797P2202D-36C25020A0024, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25024N0075 competed?
The extent of competition for 36C25024N0075 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award